Showing results (4011-4020 of 5,227) with videos related to

Sort By:
Pageof 523
Antiviral Research|September 1, 2011
Application of kinase bypass strategies to nucleoside antiviralsAdrian S Ray, Karl Y Hostetler
Antiviral Research|August 31, 2011
Prediction of drug-resistance in HIV-1 subtype C based on protease sequences from ART naive and first-line treatment failures in North India using genotypic and docking analysisJaideep S Toor, Aman Sharma, Rajender Kumar, et al.
Antiviral Research|July 13, 2011
Inhibitory effects of tricin derivative from Sasa albo-marginata on replication of human cytomegalovirusKazuhiko Akuzawa, Rie Yamada, Zhuan Li, et al.
Antiviral Research|July 5, 2011
The route of immunization with adenoviral vaccine influences the recruitment of cytotoxic T lymphocytes in the lung that provide potent protection from influenza A virusTatsuya Suda, Masaaki Kawano, Yasuhisa Nogi, et al.
Antiviral Research|July 26, 2011
Synergistic activity of baicalein with ribavirin against influenza A (H1N1) virus infections in cell culture and in miceLili Chen, Jie Dou, Zhenzhen Su, et al.
Antiviral Research|August 30, 2011
The main hepatitis B virus (HBV) mutants resistant to nucleoside analogs are susceptible in vitro to non-nucleoside inhibitors of HBV replicationGaëtan Billioud, Christian Pichoud, Gerhard Puerstinger, et al.
Antiviral Research|May 17, 2011
Development of Vaccinia reporter viruses for rapid, high content analysis of viral function at all stages of gene expressionKen Dower, Kathleen H Rubins, Lisa E Hensley, et al.
Antiviral Research|June 7, 2011
Inhibition of influenza virus-induced NF-kappaB and Raf/MEK/ERK activation can reduce both virus titers and cytokine expression simultaneously in vitro and in vivoRuth Pinto, Susanne Herold, Lidija Cakarova, et al.
Antiviral Research|June 15, 2011
Lopinavir shows greater specificity than zinc finger ejecting compounds as a potential treatment for human papillomavirus-related lesionsIngeborg Zehbe, Christina Richard, Kyle F Lee, et al.
Antiviral Research|May 31, 2011
Development of hepatitis C virus chimeric replicons for identifying broad spectrum NS3 protease inhibitorsJoseph Binder, Selwyna Tetangco, Megan Weinshank, et al.
Pageof 523